Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Translational Psychiatry
|
June 10, 2023
Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial
Kelly Allott, Hok Pan Yuen, Lara Baldwin, et al.
The Lancet. Psychiatry
|
August 3, 2019
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial
Christopher G Davey, Andrew M Chanen, Sarah E Hetrick, et al.
Early Intervention in Psychiatry
|
November 30, 2018
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol
Amber Weller, John Gleeson, Mario Alvarez-Jimenez, et al.
Early Intervention in Psychiatry
|
November 7, 2015
Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin
Amelia L Quinn, Olivia M Dean, Christopher G Davey, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
December 8, 2020
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Seetal Dodd, Michael Bauer, Andre F Carvalho, et al.
Biological Psychiatry
|
June 24, 2023
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
G Paul Amminger, Simon Rice, Christopher G Davey, et al.
Bipolar Disorders
|
September 4, 2019
An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder
Gianni L Faedda, Ross J Baldessarini, Ciro Marangoni, et al.
BMC Medicine
|
January 18, 2020
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
Michael Berk, Mohammadreza Mohebbi, Olivia M Dean, et al.
The Australian and New Zealand Journal of Psychiatry
|
September 12, 2025
Addressing the unmet needs of bipolar disorder in Australia and beyond
Sue M Cotton, Melissa Hasty, Philip Mitchell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 30, 2025
Essential information about chronobiology and chronotherapy for the optimal care of people with bipolar disorders: an international expert consensus
Jacob J Crouse, Victoria Loblay, Anthony Jorm, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Translational Psychiatry
|
June 10, 2023
Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial
Kelly Allott, Hok Pan Yuen, Lara Baldwin, et al.
The Lancet. Psychiatry
|
August 3, 2019
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial
Christopher G Davey, Andrew M Chanen, Sarah E Hetrick, et al.
Early Intervention in Psychiatry
|
November 30, 2018
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol
Amber Weller, John Gleeson, Mario Alvarez-Jimenez, et al.
Early Intervention in Psychiatry
|
November 7, 2015
Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin
Amelia L Quinn, Olivia M Dean, Christopher G Davey, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
December 8, 2020
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Seetal Dodd, Michael Bauer, Andre F Carvalho, et al.
Biological Psychiatry
|
June 24, 2023
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
G Paul Amminger, Simon Rice, Christopher G Davey, et al.
Bipolar Disorders
|
September 4, 2019
An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder
Gianni L Faedda, Ross J Baldessarini, Ciro Marangoni, et al.
BMC Medicine
|
January 18, 2020
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
Michael Berk, Mohammadreza Mohebbi, Olivia M Dean, et al.
The Australian and New Zealand Journal of Psychiatry
|
September 12, 2025
Addressing the unmet needs of bipolar disorder in Australia and beyond
Sue M Cotton, Melissa Hasty, Philip Mitchell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 30, 2025
Essential information about chronobiology and chronotherapy for the optimal care of people with bipolar disorders: an international expert consensus
Jacob J Crouse, Victoria Loblay, Anthony Jorm, et al.
Page
of 9